Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
Can you apply?
This grant is for researchers seeking high-throughput sequencing and genotyping services from a specialized NIH resource center. Eligible applicants include academic institutions, research organizations, and investigators with IRB-approved research projects involving inherited disease genetics. Projects must aim to identify disease-causing genes or variants, or classify well-characterized specimens using genomic data. Clinical trials are explicitly not eligible under this mechanism.
Key dates
- Jun 9, 2026 Applications open
- Sep 3, 2026 Application deadline in 82 days
- Dec 4, 2026 Award announced
- Dec 4, 2026 Project start
Program description
The Center for Inherited Disease Research (CIDR) carries out high-throughput genotyping and sequencing and supports statistical genetics services designed to 1) aid identification of genes or genetic modifications that contribute to human health and disease or 2) enhance the classification and characterization of well-phenotyped specimens by the addition of genotype or next-generation sequence data. The laboratory specializes in genomic services that cannot be efficiently carried out in individual investigator laboratories. CIDR provides the most up-to-date platforms, services, and statistical genetic support. This is an NIH-wide initiative that is administered by NHGRI. Information about current services offered can be accessed via: https://cidr.jhmi.edu.
Who can apply
Eligible applicants
How to apply
Application links
Key dates & requirements
Required documents
- IRB approval or approval letter
- Research protocol and specific research aims
- Detailed sample phenotype data and descriptions
- Statistical analysis plan
- Budget justification for sequencing services requested
- Letters of support from collaborators (if applicable)
Program contact
- 👤 CIDR Team
- 📧 nhgri-research-funding@nih.gov
- 📞 Please contact via e-mail.
Funding track record
Recent awards under CFDA 93.172 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$36,101,109
-
$34,574,245
-
$32,186,204
-
$30,195,606
-
$26,495,937
-
$26,020,371
-
$24,964,130
-
$24,413,854
-
$23,757,911
-
$22,364,647
Top States by Funding
- CA 19 awards $308.5M
- MA 15 awards $288.7M
- WA 9 awards $135.9M
- NY 6 awards $93.6M
- NC 4 awards $82.3M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.172). How funding has trended year over year.
| 2024 | $452,727,668 | |
| 2025 | $423,878,429 | |
| 2026 est. | $9,989,158 |
FAQ
Who can apply for CIDR services?
Academic institutions, research centers, and individual investigators can access CIDR services. Your project must have IRB approval and focus on identifying genes or variants related to inherited diseases or characterizing specimens through genomic analysis.
Are clinical trials eligible?
No. This grant mechanism explicitly excludes clinical trial studies. Your project must focus on discovery or specimen characterization research.
What services does CIDR provide?
CIDR offers high-throughput genotyping, whole-genome sequencing, exome sequencing, and statistical genetics support. Services target research questions that cannot be easily conducted in individual labs.
What makes a competitive application?
Strong applications clearly articulate the genetic research question, demonstrate the need for high-throughput services, and provide well-phenotyped samples. Detailed phenotype data strengthens applications.
When is the deadline?
The deadline is September 3, 2026. Check the CIDR website for application submission instructions and any updates.
💡 Tips for applicants
- Contact CIDR staff early to discuss your research question and determine if services are appropriate for your study.
- Provide detailed phenotype data and sample descriptions; CIDR's statistical support depends on clear case definitions.
- Ensure your project is IRB-approved or include an IRB approval plan in your application.
- Review current service offerings on the CIDR website; sequencing methods and platforms are regularly updated.
- Budget realistically for sample preparation and sequencing depth based on CIDR's fee schedule and your research design.
⚠️ Common mistakes
Vague phenotype descriptions weaken applications and limit CIDR's ability to provide statistical genetics support. Requesting services available in standard investigator labs rather than specialized high-throughput capacity reduces competitiveness. Failing to confirm IRB approval or including ineligible clinical trial designs leads to rejection.
Similar grants
- OPEN Rural Community Health Integration2026 — New York State Department of Health
- OPEN FY26 Bureau of Land Management Rangeland Resource Management – Bureau wide — Bureau of Land Management
- OPEN FY26 Bureau of Land Management Cultural and Paleontological Resource Management – Bureau wide — Bureau of Land Management
- OPEN FY26 Bureau of Land Management Youth Conservation Corps – Bureau wide — Bureau of Land Management
- OPEN Infertility Training Center — Office of the Assistant Secretary for Health